glp 1 and depression does help with What do the studies actually show about GLP-1s Now, new research suggests that

The treatment is not FDA approved, and its use is not regulated by governing bodies, raising concerns about potential side effects and safety issues

Additional research by Stanley and colleagues showed that tesamorelin reduced hepatic (liver) fat by approximately 37% in individuals with fatty liver disease, making it one of the few compounds that addresses both visceral adiposity and its downstream consequence of liver fat accumulation

People taking weight loss medications often explore L-carnitine because it may enhance fat utilization during calorie restriction

Furthermore, in rodent models, L-carnitine has been shown to inhibit leukocyte apoptosis through its free-radical scavenging activities 6